A low-cost nonvalved aqueous drainage implant significantly reduced IOP and glaucoma medication use in patients with refractory glaucoma, according to a retrospective review.
“The design inspiration of this cost-effective indigenously manufactured nonvalved device is the Baerveldt glaucoma implant (Johnson & Johnson Vision), which is not available in India. Its performance appears to be rather similar, and at 2 years, it has a low failure rate with achievement of low target intraocular pressure at substantially reduced number of medications,” study co-author Vanita Pathak Ray,
Uncategorized